sb 203580 has been researched along with mercury in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (mercury) | Trials (mercury) | Recent Studies (post-2010) (mercury) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 29,563 | 116 | 11,362 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berti, E; Burlando, B; Magnelli, V; Panfoli, I; Viarengo, A | 1 |
Bark, H; Choi, CH; Kim, SH | 1 |
2 other study(ies) available for sb 203580 and mercury
Article | Year |
---|---|
Ligand-independent tyrosine kinase signalling in RTH 149 trout hepatoma cells: comparison among heavy metals and pro-oxidants.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Copper; DNA-Binding Proteins; Dose-Response Relationship, Drug; Genistein; Hydrogen Peroxide; Imidazoles; Ligands; Mercury; Metals, Heavy; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oxidants; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Pyridines; Receptor Protein-Tyrosine Kinases; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Tyrosine | 2003 |
Mercury induces multidrug resistance-associated protein gene through p38 mitogen-activated protein kinase.
Topics: Blotting, Western; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Chemokines, CC; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Imidazoles; Mercury; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazolium Salts; Thiazoles | 2005 |